SCHEMBL7294012

SCHEMBL7294012

CS(=O)(=O)NC#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27989275 0.72
SCHEMBL482942 0.70
SCHEMBL54557 0.69
SCHEMBL7612633 0.69
SCHEMBL27917970 0.67
SCHEMBL25764594 0.67
SCHEMBL18161393 0.67
SCHEMBL21666133 0.67
SCHEMBL2703530 0.67
SCHEMBL12633320 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113149983-B Tyrosine kinase inhibitors 普林斯匹亚生物制药公司 2024-03-29 CN disclosed
WO-2023093880-A1 LITHIUM-ION BATTERY 珠海冠宇电池股份有限公司 2023-06-01 WO disclosed
CN-110117257-B P2Y12 receptor antagonist containing guanidyl as well as preparation method and application thereof 安徽省新星药物开发有限责任公司 2022-12-06 CN disclosed
WO-2019149259-A1 P2Y12 RECEPTOR ANTAGONIST CONTAINING GUANIDYL, AND PREPARATION METHOD AND USE THEREOF 安徽省新星药物开发有限责任公司 2019-08-08 WO disclosed
EP-2994469-B1 BENZIMIDAZOLE DERIVATIVES AS BROMODOMAIN INHIBITORS GILEAD SCIENCES INC (US) 2018-12-19 EP disclosed
CN-105324379-B Benzimidazole derivatives as bromodomain inhibitors 吉利德科学公司 2018-12-04 CN disclosed
US-20180282316-A1 BENZIMIDAZOLE DERIVATIVES AS BROMODOMAIN INHIBITORS GILEAD SCIENCES, INC. 2018-10-04 US disclosed
US-10017501-B2 Benzimidazole derivatives as bromodomain inhibitors GILEAD SCIENCES, INC. (US) 2018-07-10 US disclosed
US-10017501-B2 Benzimidazole derivatives as bromodomain inhibitors GILEAD SCIENCES, INC. (US) 2018-07-10 US disclosed
US-9884841-B2 Small molecule inhibitors of Mcl-1 and uses thereof THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2018-02-06 US disclosed
US-20140336190-A1 BENZIMIDAZOLE DERIVATIVES AS BROMODOMAIN INHIBITORS GILEAD SCIENCES, INC. (US) 2014-11-13 US disclosed
US-8593787-B2 Electrochemical capacitor having lithium containing electrolyte CORNING INCORPORATED (US) 2013-11-26 US disclosed
EP-2561528-A2 ELECTROCHEMICAL CAPACITOR HAVING LITHIUM CONTAINING ELECTROLYTE Corning Incorporated (US) 2013-02-27 EP disclosed
US-20090246481-A1 DISPERSION OF WATER-INSOLUBLE COLORANT, METHOD OF PRODUCING SUBSTANCE CONTAINING WATER-INSOLUBLE COLORANT, FINE PARTICLES OF WATER-INSOLUBLE COLORANT, DISPERSING AGENT FOR WATER-INSOLUBLE COLORANT, AND RECORDING LIQUID, INK SET, PRINTED ARTICLE, METHOD OF FORMING IMAGE AND IMAGE FORMING APPARATUS USING THE SAME FUJIFILM CORPORATION (JP) 2009-10-01 US disclosed
US-20030013124-A1 Solid support for use in monitoring hybridization reactions KUO JENNIFER M LU (US) 2003-01-16 US disclosed
WO-2002094776-A2 SURFACES FOR COVALENT ATTACHMENT OF LIGANDS LINDEN TECHNOLOGIES, INC. (US) 2002-11-28 WO disclosed
EP-0771209-A4 NOVEL PEPTIDES MERCK & CO INC (US) 2000-04-26 EP disclosed
EP-0771209-A2 NOVEL PEPTIDES Merck &amp; Co., Inc. (a New Jersey corp.) (US) 1997-05-07 EP disclosed
WO-1996000503-A1 NOVEL PEPTIDES MERCK & CO., INC. (US) 1996-01-11 WO disclosed
EP-0376355-A1 2-Quaternary heteroarylalkythio carbapenems MERCK & CO. INC. (US) 1990-07-04 EP disclosed